|
May 24
|
Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Shift From Loss To Profit
|
|
May 23
|
Can't Kick the Bud? Achieve's Cytisinicline Proves Promising in Phase 3 Smoking Cessation Trial
|
|
May 23
|
Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial
|